ILMN

ILMN

USD

Illumina Inc. Common Stock

$121.900+1.690 (1.406%)

实时价格

Healthcare
Diagnostics & Research
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$120.210

最高价

$122.075

最低价

$119.360

成交量

1.86M

公司基本面

市值

18.6B

所属行业

Diagnostics & Research

国家/地区

United States

交易统计

平均成交量

1.68M

交易所

NMS

货币

USD

52周价格范围

最低价 $68.7当前价 $121.900最高价 $153.06

AI分析报告

最后更新: 2025年11月3日
由AI生成数据来源: Yahoo Finance, Bloomberg, SEC

Illumina (ILMN): Decoding Market Signals Amid Analyst Upgrades and AI Predictions

Price Action Reality Check

After a rocky Q3 that saw the stock bottom out at $91.30 (Sep 25), Illumina exploded higher in late October. The October 31 print of $123.54 marked a 24.7% single-day surge--the largest move since early August. This came on 6.5x average volume, suggesting institutional buying power behind the rally. While the stock now sits 44% above its 52-week low and 24% below its 52-week high, the aggressive jump leaves technical questions about sustainability.

News Sentiment Breakdown

Analysts split on Illumina’s prospects:

  • Evercore ISI (Outperform, $142 target) and UBS (Neutral, $120) highlight bullish extremes
  • Barclays ($100 target) remains cautious amid upgrades
  • Mixed messaging: 21.9% average upside across analyst targets vs. current $123.54 price

The October 30 earnings release appears to be the catalyst for this divergence. Technicals show conflicting signals:

  • Bullish: RSI at

相关新闻

Analyst Upgrades

Barclays Maintains Underweight on Illumina, Raises Price Target to $100

Barclays analyst Luke Sergott maintains Illumina with a Underweight and raises the price target from $95 to $100.

查看更多
Barclays Maintains Underweight on Illumina, Raises Price Target to $100
Analyst Upgrades

Canaccord Genuity Maintains Hold on Illumina, Raises Price Target to $112

Canaccord Genuity analyst Kyle Mikson maintains Illumina with a Hold and raises the price target from $105 to $112.

查看更多
Canaccord Genuity Maintains Hold on Illumina, Raises Price Target to $112
Analyst Upgrades

JP Morgan Maintains Neutral on Illumina, Raises Price Target to $105

JP Morgan analyst Casey Woodring maintains Illumina with a Neutral and raises the price target from $100 to $105.

查看更多
JP Morgan Maintains Neutral on Illumina, Raises Price Target to $105
Analyst Upgrades

TD Cowen Maintains Hold on Illumina, Raises Price Target to $115

TD Cowen analyst Dan Brennan maintains Illumina with a Hold and raises the price target from $110 to $115.

查看更多
TD Cowen Maintains Hold on Illumina, Raises Price Target to $115
Analyst Upgrades

UBS Maintains Neutral on Illumina, Raises Price Target to $120

UBS analyst John Sourbeer maintains Illumina with a Neutral and raises the price target from $110 to $120.

查看更多
UBS Maintains Neutral on Illumina, Raises Price Target to $120
Analyst Upgrades

Evercore ISI Group Maintains Outperform on Illumina, Raises Price Target to $142

Evercore ISI Group analyst Vijay Kumar maintains Illumina with a Outperform and raises the price target from $132 to $142.

PR Newswire

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025

Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the third quarter of fiscal year 2025. "I am...

AI预测Beta

AI建议

看涨

更新于: 2025年11月10日 11:53

看跌中性看涨

67.3% 置信度

风险与交易

风险等级3/5
中风险
适合于
保守
交易指南

入场点

$121.46

止盈点

$129.89

止损点

$109.68

关键因素

PDI 9.3 is above MDI 5.0 with ADX 15.0, suggesting bullish trend
当前价格非常接近支撑水平$121.27,表明有强烈的买入机会
交易量是平均值的4.5倍(17,664),表明极强的买入压力
MACD 0.1239低于信号线0.1247,表明看跌交叉

保持更新

设置价格提醒,获取AI分析更新和实时市场新闻。